Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
ZBH
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Citi reiterates these 2 medtech stocks as its top picks in the sector
Investing.com-- Citi reiterated its top picks in the medtech sector, highlighting Abbott Laboratories and Dexcom as standout opportunities while pointing to diverging fortunes across the industry. Before you buy NVIDIA: our AI model's stoc…
Are Investors Undervaluing Baxter International (BAX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to…
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
WARSAW, Ind., Oct. 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be webcast on Wednesday, November 4, 2026, at…
Moderna, Illumina lead healthcare gains in September as medtech drags
[Close-Up Shot of Scientists Hands typing Data in Laptop in Laboratory] Tom Werner Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV [https://seekingalpha.com/symbol/XLV]) f…
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Centene in focus
Wall Street closed higher Friday as easing Treasury yields and lower oil prices supported equities, with investors continuing to monitor developments surrounding the Strait of Hormuz. The blue-chip Dow (DJI [https://seekingalpha.com/symbol…
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings?
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q2 Earnings? Zimmer Biomet currently trades at $91.50 per share and has shown little upside over the past six months, posting a middling return of 4.4%. The stock also fell short of the S&P 500'…
Zimmer Biomet Holdings (ZBH) Pushes Cost Reset Plans, Is It Still 17% Below Fair Value?
Zimmer Biomet Holdings: recent performance and context Zimmer Biomet Holdings (ZBH) has drawn investor attention after a stretch of weaker share performance, with the stock down 1.3% over the past day and 10.5% over the past month. At a sh…
Smoke Evacuation Systems Market Forecasts Growth from $0.20B (2025) to $0.30B by 2031, Profiling CONMED, Medtronic, Stryker & Becton Dickinson
Company Logo The global smoke evacuation systems market is forecast to grow from USD 0.20 billion in 2025 to USD 0.30 billion by 2031, at a 7.5% CAGR. Growth is driven by rising minimally invasive, electrosurgical and laparoscopic procedur…
Medical Robots Market Forecasts Growth from $20.6B (2026) to $41.7B by 2031, Profiling Intuitive Surgical, Stryker, Zimmer Biomet & Medtronic
Company Logo The global medical robots market is projected to grow from USD 20.6 billion in 2026 to USD 41.7 billion by 2031, at a 15.1% CAGR. Growth is driven by demand for minimally invasive surgery, healthcare automation, precision proc…
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as…
Minimally Invasive Robotic Surgical System Market Global Report 2026: Benchmark Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker and Zimmer Biomet Now
Company Logo Players: Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet. Profile covers competitors, segments, regional shares, trends and opportunities. Minimally Invasive Robotic Surgical System MarketMinimally Inv…
3 Mid-Cap Stocks with Open Questions Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract sign…
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
Intuitive Surgical ISRG is focusing on Ambulatory surgery centers (ASCs) as an important channel for its robotic-surgery expansion. The company is targeting the low-cost ASC segment with refurbished XiR platforms priced below its flagship…
Image from Pixabay Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over…
Image from Pexels Intuitive Surgical (ISRG), maker of the da Vinci surgical robots, trades at about $382, some 36% below its 52-week high. Even so, you pay about 35.9 times trailing adjusted earnings. That is normalized net income with sto…
Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead
Key Points Interested in Edwards Lifesciences Corporation? Here are five stocks we like better. CMS's updated TAVR coverage policy provides greater flexibility for patient evaluations, procedure staffing and hospital program requirements,…
Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2. Today, we are…
Is Zimmer Biomet Stock Underperforming the Nasdaq?
Zimmer Biomet Holdings Inc HQ photo-by jetcityimage via iStock With a market cap of $18.8 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology company specializing in musculoskeletal healthcare solutions. The company…
Photo by Rigby40 on Pixabay Intuitive Surgical (ISRG) trades near $370, about 38% below its 52-week high, after growth in its US robotic-surgery procedures slowed. Selling a put pays you now for agreeing to buy the shares much lower, and y…
How Zimmer Biomet’s New Americas and Robotics Leadership Structure At Zimmer Biomet Holdings (ZBH) Has Changed Its Investment Story
Zimmer Biomet Holdings, Inc. recently announced a major reshuffling of its leadership structure, effective October 1, 2026, promoting Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurge…
3 Cash-Producing Stocks We Find Risky Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. C…
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and Data WARSAW, Ind., Sept. 8, 2026 /PRNew…
Investing.com -- Stryker Corp. shares dropped as much as 7.7% on Tuesday morning after company executives discussed ongoing problems in its peripheral vascular and joint replacement operations at an industry conference. The company present…
Global Surgical Robots Market to Reach $10.6 Billion in 2026, Driven by AI Integration and Minimally Invasive Surgery
Company Logo Report Features In-Depth Profiles of Abbott, Great Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Panasonic, Renishaw, Siemens Healthineers, Smith+Nephew, Stryker, Zimmer Biomet, and Freehand Dublin, Sept. 07, 202…
Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
It has been about a month since the last earnings report for Zimmer Biomet (ZBH). Shares have added about 1.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leadi…
1 Profitable Stock to Keep an Eye On and 2 That Underwhelm
1 Profitable Stock to Keep an Eye On and 2 That Underwhelm Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive…
1 Value Stock with Impressive Fundamentals and 2 We Question
1 Value Stock with Impressive Fundamentals and 2 We Question The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are…
ISRG Stock: The Best House On The Block Costs The Most
Photo by Pexels on Pixabay In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium. Intuitive Surgical (ISRG), the pi…
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockhol…
The Hospital Bet That Reframes The Intuitive Surgical Stock Story
Photo by 127071 on Pixabay While investors fixate on a slowdown in current procedures, hospitals are accelerating their investment in the company's core platform, revealing a crucial, under-appreciated strength. When a market leader's stoc…
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
Zimmer Biomet ZBH appears well positioned for growth in the coming quarters, supported by healthy orthopedic procedure demand. Also, the company is experiencing strong adoption of Z1, HAMMR and OrthoGrid. Yet, intense competition and an el…
Zimmer Biomet (ZBH) Stock Still Looks Discounted After a 28% Five Year Slide
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Zimmer Biomet Holdings has seen its share price decline about 27.9% over the past five years, yet the stock still screens as attrac…
Is ISRG's Software Strategy Becoming as Important as Its Robots?
Intuitive Surgical's ISRG software is increasingly becoming a core component of the da Vinci 5 value proposition, potentially extending the platform's competitive moat beyond hardware. The company rolled out the first phase of more than 10…
AM Applications Analysis: Parts Produced 2025-2034 Delivers 10-Year Additive Manufacturing Market Forecast
Company Logo Supported by real market data through Q4 2025 and 10-year projections, this study delivers a granular evaluation across metal and polymer part categories (prototypes, tooling, end-use production components) and major consuming…
Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks
Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how surgical eq…